Evan Melrose

Evan Melrose is the founding managing director of Spindletop Capital in Austin. Prior to Spindletop, he was founding managing director of PTV Sciences, an Austin venture capital firm, and a director with Burrill & Company, a San Francisco-based private equity/venture capital firm. While at Burrill he managed investments on behalf of limited partners including IBM, Aventis, Proctor & Gamble, ADM, and Bayer. Dr. Melrose has public board and operating experience including partnerships and IPOs. Current and prior board membership include Bioventus, QSpex, Avanzar Medical, IntersectENT, Asuragen, BioSET, BioForm Medical (Nasdaq: BFRM), Biomimetic Therapeutics (Nasdaq: BMTI), Inhibitex (Nasdaq: INHX), and Insite Vision. He has held faculty appointments at the UCSF, UPenn, and currently at Baylor College of Medicine. His primary care practice included obstetrics, pediatrics, and emergency medicine.